Antibody Drug Conjugate
Antibody Drug Conjugates (ADCs) are a class of drugs in which monoclonal antibodies are conjugated with Highly Active Pharmaceutical Ingredients (HAPIs). ADCs are particularly effective because they exhibit selective cytotoxicity by targeting only a small subset of cells. BioReliance, along with SAFC, offers comprehensive and coordinated services for the development, manufacture, and testing of your ADC.
BioReliance has years of experience in the production and testing of monoclonal antibodies (mAb), giving us the ability to provide complete testing for the bulk mAb product. SAFC offers a whole suite of services needed for ADCs including:
- Linkers and cytotoxic agents
- Formulation development
- Fill/finish including lyophilization
- Process development
- Technology transfer
- Analytical method development and validation
- Stability studies for bulk drug substance and drug product
Together, we provide a one stop shop to meet all your ADC development needs.
Copyright © 2017 Sigma-Aldrich Co. LLC. All Rights Reserved. Reproduction of any materials from the site is strictly forbidden without permission. Sigma-Aldrich brand products are sold exclusively through Sigma-Aldrich Co. LLC. Sigma-Aldrich Corp. is a subsidiary of Merck KGaA, Darmstadt, Germany Terms | Privacy